CSF biomarkers for mild cognitive impairmentBLENNOW, K.Journal of internal medicine. 2004, Vol 256, Num 3, pp 224-234, issn 0954-6820, 11 p.Conference Paper

Modelling minimum air temperature in partially and clear felled forestsBLENNOW, K.Agricultural and forest meteorology. 1998, Vol 91, Num 3-4, pp 223-235, issn 0168-1923Article

Justification des marqueurs biologiques dans la maladie d'AlzheimerDE LEON, M.J; BLENNOW, K.Maladie d'Alzheimer et déclin cognitif. Recherche et pratique clinique. Volume 13. 2008, pp 26-39, 14 p.Book Chapter

USE OF CSF BIOMARKERS IN ALZHEIMER'S DISEASE CLINICAL TRIALSBLENNOW, K; ZETTERBERG, H.The Journal of nutrition, health & aging. 2009, Vol 13, Num 4, pp 358-361, issn 1279-7707, 4 p.Article

From heath to forest : Land-use transformation in Halland, SwedenBLENNOW, K; HAMMARLUND, K.Ambio. 1993, Vol 22, Num 8, pp 561-567, issn 0044-7447Article

Pathogenetic basis of vascular dementiaWALLIN, A; BLENNOW, K.Alzheimer disease and associated disorders. 1991, Vol 5, Num 2, pp 91-102, issn 0893-0341Article

Mild Cognitive Impairment (MCI) et maladie d'Alzheimer débutante place des bio-marqueurs dans le LCRANDREASEN, N; BLENNOW, K.Maladie d'Alzheimer et déclin cognitif. Recherche pratique et clinique. Volume 10. 2005, pp 115-119, isbn 2-914-37785-1, 5 p.Book Chapter

Clinical heterogeneity of probable Alzheimer's diseaseBLENNOW, K; WALLIN, A.Journal of geriatric psychiatry and neurology. 1992, Vol 5, Num 2, pp 106-113, issn 0891-9887Article

Neurologic motor signs in early and late onset Alzheimer's diseaseWALLIN, A; BLENNOW, K.Dementia (Basel). 1992, Vol 3, Num 5-6, pp 314-319, issn 1013-7424Article

JUSTIFICATION DES MARQUEURS BIOLOGIQUES DANS LA MALADIE D'ALZHEIMERDE LEON, M. J; BLENNOW, K.Age & nutrition (Paris). 2009, Vol 20, Num 1, pp 18-24, issn 1158-0259, 7 p.Article

Heterogeneity of vascular dementia: mechanisms and subgroupsWALLIN, A; BLENNOW, K.Journal of geriatric psychiatry and neurology. 1993, Vol 6, Num 3, pp 177-188, issn 0891-9887Article

Increased CSF/serum albumin ratio : a recurrent finding in violent offendersANCKARSÄTER, H; FORSMAN, A; BLENNOW, K et al.Acta neurologica scandinavica. 2005, Vol 112, Num 1, pp 48-50, issn 0001-6314, 3 p.Article

Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implicationsSJÖGREN, M; FOLKESSON, S; BLENNOW, K et al.Journal of neurology, neurosurgery and psychiatry. 2004, Vol 75, Num 8, pp 1107-1111, issn 0022-3050, 5 p.Article

The activity in the CNS catecholaminergic systems covaries with thyroid hormone metabolism in humansYHEDE, R; BLENNOW, K; FORSMAN, A et al.Journal of neural transmission. 2003, Vol 110, Num 12, pp 1369-1373, issn 0300-9564, 5 p.Article

Clinical subgroups of the Alzheimer syndromeWALLIN, A; BLENNOW, K.Acta neurologica Scandinavica. Supplementum. 1996, Vol 93, Num 165, pp 51-57, issn 0065-1427Article

A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's diseaseHESSE, C; BOGDANOVIC, N; DAVIDSSON, P et al.Dementia and geriatric cognitive disorders. 1999, Vol 10, Num 6, pp 452-459, issn 1420-8008Article

A new procedure for detecting brain-specific proteins in cerebrospinal fluidDAVIDSSON, P; EKMAN, R; BLENNOW, K et al.Journal of neural transmission. 1997, Vol 104, Num 6-7, pp 711-720, issn 0300-9564Article

Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementiaWALLIN, A; BLENNOW, K; ROSENGREN, L. E et al.Dementia (Basel). 1996, Vol 7, Num 5, pp 267-272, issn 1013-7424Article

Neuron specific enolase in cerebrospinal fluid : a biochemical marker for neuronal degeneration in dementia disorders ?BLENNOW, K; WALLIN, A; EKMAN, R et al.Journal of neural transmission - Parkinson's disease and dementia section. 1994, Vol 8, Num 3, pp 183-191, issn 0936-3076Article

Low frequency of post-lumbar puncture headache in demented patientsBLENNOW, K; WALLIN, A; HÄGER, O et al.Acta neurologica scandinavica. 1993, Vol 88, Num 3, pp 221-223, issn 0001-6314Article

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's diseaseBLENNOW, K; HESSE, C; FREDMAN, P et al.Neuroreport (Oxford). 1994, Vol 5, Num 18, pp 2534-2536, issn 0959-4965Article

CSF studies in violent offenders: II. Blood-brain barrier dysfunction without concurrent inflammation or structure degenerationSODERSTROM, H; BLENNOW, K; MANHEM, A et al.Journal of neural transmission. 2001, Vol 108, Num 7, pp 879-886, issn 0300-9564Article

Intracerebral production of tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer disease and vascular dementiaTARKOWSKI, E; BLENNOW, K; WALLIN, A et al.Journal of clinical immunology. 1999, Vol 19, Num 4, pp 223-230, issn 0271-9142Article

Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairmentRAMAKERS, I. H. G. B; VERHEY, F. R. J; TROJANOWSKI, J. Q et al.Psychological medicine (Print). 2013, Vol 43, Num 5, pp 911-920, issn 0033-2917, 10 p.Article

Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermiaMÖRTBERG, E; ZETTERBERG, H; NORDMARK, J et al.Acta anaesthesiologica scandinavica. 2011, Vol 55, Num 9, pp 1132-1138, issn 0001-5172, 7 p.Article